• 1
    Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. Synergistic effects of (−)-epigallocatechin gallate with (−)-epicatechin, sulindac or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 1999; 59: 447.
  • 2
    Suganuma M, Ohkura Y, Okabe S, Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol 2001; 127: 6972.
  • 3
    Chisholm K, Bray BJ, Rosengren RJ. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004; 15: 88997.
  • 4
    Fujiki H, Suganuma M. Translational research on TNF-α as an endogenous tumor promoter and green tea as cancer preventive in humans. J Environ Sci Health 2005; 23: 330.
  • 5
    Fujiki H. Green tea: Health benefits as cancer preventive for humans. Chem Rec 2005; 5: 11932.
  • 6
    Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 2005; 591: 14760.
  • 7
    Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, Yoshida T. New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res 2003; 523–524: 11925.
  • 8
    Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription. Gene Dev 1992; 6: 43953.
  • 9
    Fornace AJ,Jr, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 1989; 9: 4196203.
  • 10
    Maytin EV, Ubeda M, Lin JC, Habener JF. Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res 2001; 267: 193204.
  • 11
    Kim DG, You KR, Liu MJ, Choi YK, Won YS. GADD153-mediated anticancer effects of N-(4-hydroxyphenyl)retinamide on human hepatoma cells. J Biol Chem 2002; 277: 389308.
  • 12
    Xia Y, Wong NS, Fong WF, Tideman H. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR). Int J Cancer 2002; 102: 714.
  • 13
    Scott DW, Loo G. Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis 2004; 25: 215564.
  • 14
    Satoh T, Toyoda M, Hoshino H, Monden T, Yamada M, Shimizu H, Miyamoyo K, Mori M. Activation of peroxisome proliferator-activated receptor-γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene 2002; 21: 217180.
  • 15
    Powolny A, Takahashi K, Hopkins RG, Loo G. Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells. J Cell Biochem 2003; 90: 112839.
  • 16
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Death receptor regulation and celecoxib induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004; 96: 176980.
  • 17
    Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H. Lung cancer prevention with (−)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol 2002; 20: 12339.
  • 18
    Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H. Modulation of gene expression by (−)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull 2001; 24: 8836.
  • 19
    Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 1997; 88: 63943.
  • 20
    Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, et al. Combination of IFN-α and 5-fluorouracil induces apoptosis through IFN-α/β receptor in human hepatocellular carcinoma cells. Clin Cancer Res 2005; 11: 127786.
  • 21
    Gartel AL. Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 8: 63949.
  • 22
    Yin F, Bruemmer D, Blaschke F, Hsueh WA, Law RE, Van Herle AJ. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene 2004; 23: 461423.
  • 23
    Kultz D, Madhany S, Burg MB. Hyperosmolality causes growth arrest of murine kidney cells. Induction of GADD45 and GADD153 by osmosensing via stress activated protein kinase 2. J Biol Chem 1998; 273: 1364551.
  • 24
    Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273: 1862332.
  • 25
    LoGrasso PV, Frantz B, Rolando AM, O'Keefe SJ, Hermes JD, O'Neill EA. Kinetic mechanism for p38 MAP kinase. Biochem 1997; 36: 1042227.
  • 26
    Yoshizawa S, Horiuchi T, Fujiki H. Antitumor promoting activity of (−)-epigallocatechin gallate, the main constituent of “Tannin” in green tea. Phytother Res 1987; 1: 447.
  • 27
    Yano T, Sugio K, Yamazaki K, Kase S, Yamaguchi M, Ondo K, Sugimachi K. Direct IFNluence of interferon-gamma on proliferation and cell-surface antigen expression of non-small cell lung cancer cells. Lung Cancer 2000; 30: 16974.
  • 28
    Szabo E, Riffe ME, Steinberg SM, Birrer MJ, Linnoila RI. Altered cJUN expression: an early event in human lung carcinogenesis. Cancer Res 1996; 56: 30515.
  • 29
    Moghal N, Neel BG. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol Cell Biol 1995; 15: 394559.
  • 30
    McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd 153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001; 21: 124959.
  • 31
    Gotoh T, Terada K, Oyadomari S, Mori M. hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 2004; 11: 390402.
  • 32
    Zinszner H, Kuroda M, Wang XZ, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12: 98295.
  • 33
    Rong R, Montalbano J, Jin W, Zhang J, Garling M, Sheikh MS, Huang Y. Oncogenic Ras-mediated downregulation of gadd153/CHOP is required for Ras induced cellular transformation. Oncogene 2005; 24: 486772.
  • 34
    Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005; 113: 6609.
  • 35
    Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001; 7: 42209.
  • 36
    Corazzari M, Lovat PE, Oliverio S, Di Sano F, Donnorso RP, Redfern CPF, Piacentini M. Fenretinide: A p53-independent way to kill cancer cells. Biochem Biophys Res Commun 2005; 331: 81015.
  • 37
    Wu Y, Zhang H, Dong Y, Park YM, Ip C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res 2005; 65: 90739.
  • 38
    Cao S, Durrani FA, Rustum YM. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 2004; 10: 25619.
  • 39
    Fujiki H, Suganuma M, Matsuyama S, Miyazaki K. Cancer prevention with green tea polyphenols for the general population, and for patients following cancer treatment. Current Cancer Therapy Rev 2005; 1: 10914.
  • 40
    Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study. Proc AACR 2005; 96: 1041.
  • 41
    Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn MSP, Anderson WF, Zauber A, Hawk E, Bartagnolli M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New Engl J Med 2005; 352: 107180.